Corporate Overview

Print Page Print Page        E-mail Page Email Page        RSS Feeds RSS        E-mail Alerts Email Alerts        Financial Tear Sheet Tear Sheet
Corporate Profile

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.

Stock Quote
ALKS (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$33.98
Change (%) Stock is Down 1.52 (4.28%)
Volume544,788
Data as of 12/13/18 1:56 p.m. ET
Minimum 20 minute delay
Refresh quote »
News Releases
DateTitle 
11/30/18Statement by Richard Pops, Chairman and CEO of Alkermes on the Annual CDC Report on Drug Overdose Deaths and Suicide Mortality in the United StatesPrinter Friendly Version
11/29/18Alkermes Announces Positive Topline Results From ENLIGHTEN-2 Phase 3 Study of ALKS 3831 in Patients With SchizophreniaPrinter Friendly Version
11/06/18Alkermes' Corporate Presentation to be Webcast at Upcoming Healthcare ConferencesPrinter Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
FirmAnalystPhone
B. Riley FBRDavid Buck646.885.5416
Bank of America Merrill Lynch Jason Gerberry646.743.0180
Cantor FitzgeraldBrandon Folkes212.294.8081
Citi ResearchLiav Abraham212.816.1635
Cowen & Co.Chris Shibutani, M.D.617.946.3733
Credit SuisseVamil Divan212.538.5394
Evercore ISIUmer Raffat212.888.3905
Goldman Sachs & Co.Terence Flynn212.357.5057
Jefferies & Co., Inc.Biren Amin212.284.8162
JPMorgan Securities, Inc.Cory Kasimov212.622.5266
LeerinkMarc Goodman212.277.6137
Morgan Stanley ResearchDavid Risinger212.761.6494
Piper JaffrayDanielle Brill212.284.5025
StifelPaul Matteis617.488.4485

Alkermes plc is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Alkermes plc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Alkermes plc or its management. Alkermes plc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

For easy reference, we list below answers to many of the questions we hear most often.

1.Where is Alkermes incorporated?
2.What exchange is Alkermes stock listed on? What is Alkermes' stock symbol?
3.What is Alkermes' CUSIP #?
4.Where is Alkermes' headquarters?
5.Can I purchase shares directly from the company?
6.Who is Alkermes' transfer agent?
7.I've lost my stock certificates; how can I replace them?
8.I'm a shareholder; who should I notify of a change of address?
9.What is Alkermes' fiscal year?
1.Where is Alkermes incorporated?
 Alkermes plc is incorporated in Dublin, Ireland.

2.What exchange is Alkermes stock listed on? What is Alkermes' stock symbol?
 Alkermes is listed on the NASDAQ Stock Exchange under the ticker symbol ALKS.

3.What is Alkermes' CUSIP #?
 The CUSIP # for Alkermes' securities is G01767 105

4.Where is Alkermes' headquarters?
 Alkermes plc is headquartered in Dublin, Ireland. The company also has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio.

5.Can I purchase shares directly from the company?
 No. Alkermes does not have a direct stock purchase plan. You may purchase shares of Alkermes through a broker.

6.Who is Alkermes' transfer agent?
 Alkermes' transfer agent is Computershare (formerly Equiserve Trust company). You can reach Computershare at:

P.O. Box 505000
Louisville, KY 40233
Phone: 866-281-3760

7.I've lost my stock certificates; how can I replace them?
 In the event that you lose your stock certificates, you should contact our transfer agent, Computershare (formerly Equiserve Trust Company). You can reach Computershare at:

Computershare
P.O. Box 505000
Louisville, KY 40233
Phone: 866-281-3760

8.I'm a shareholder; who should I notify of a change of address?
 If you hold your shares through your broker and you change your address, please contact your broker. If you hold your shares in registered form and you change your address, you should contact our transfer agent, Computershare (formerly Equiserve Trust Company). You can reach Computershare at:

Computershare
P.O. Box 505000
Louisville, KY 40233
Phone: 866-281-3760

9.What is Alkermes' fiscal year?
 Alkermes' fiscal year begins January 1 and ends December 31 each year. The quarterly breakdown is as follows:

  • Q1 January 1- March 31

  • Q2 April 1 – June 30

  • Q3 July 1 - September 31

  • Q4 October 1 – December 31

  • NASDAQ

    Stock Quote

    ALKS (Common Stock)
    ExchangeNASDAQ (US Dollar)
    Price$33.98
    Change (%) Stock is Down 1.52 (4.28%)
    Volume544,788
    Data as of 12/13/18 1:56 p.m. ET
    Minimum 20 minute delay
    Refresh quote

    E-mail Alerts